RNAC EPS Estimates
Cartesian Therapeutics, Inc.
$6.69
+$0.23(+3.56%)
--
Overall
--
Value
--
Tech
--
Quality
Market Cap
--
Volume
113.59K
52W Range
$5.60 - $11.00
Target Price
--
RNAC EPS estimates for Cartesian Therapeutics, Inc.. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
RNAC EPS Estimates
- EPS growth, 3-year
- -100.00%
| Fiscal year | EPS |
|---|---|
| 2025 | $-5.02 |
| 2024 | $-4.48 |
| 2023 | $-49.80 |
| 2022 | $7.20 |
| 2021 | $-6.60 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RNAC | $6.69 | +3.6% | 113.59K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Cartesian Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW